Diageo, UP Fintech, RBB Bancorp, Regencell Bioscience, and China SXT Pharmaceuticals are the five Chinese stocks to watch today, according to MarketBeat's stock screener tool. “Chinese stocks” refers to shares of companies based in China or closely tied to the Chinese economy, traded on mainland exchanges, Hong Kong, or international markets such as U.S. exchanges. Investors may access them directly or through ADRs and ETFs, but should consider factors such as government regulation, accounting standards, geopolitical tensions, and currency risk. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.
Diageo (DEO)
Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.
Shares of NYSE:DEO traded up $3.88 during trading on Wednesday, reaching $97.92. The stock had a trading volume of 978,669 shares, compared to its average volume of 1,432,557. The firm's 50-day simple moving average is $89.66 and its 200 day simple moving average is $85.94. The company has a quick ratio of 0.62, a current ratio of 1.60 and a debt-to-equity ratio of 1.53. Diageo has a one year low of $72.45 and a one year high of $102.74.
Read Our Latest Research Report on DEO
UP Fintech (TIGR)
UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.
Shares of NASDAQ TIGR traded up $0.20 during mid-day trading on Wednesday, hitting $4.05. The stock had a trading volume of 1,524,623 shares, compared to its average volume of 3,086,895. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.10 and a current ratio of 1.10. UP Fintech has a twelve month low of $3.76 and a twelve month high of $11.35. The company has a 50 day moving average of $4.55 and a two-hundred day moving average of $5.81. The firm has a market cap of $769.23 million, a PE ratio of 6.86 and a beta of 0.65.
Read Our Latest Research Report on TIGR
RBB Bancorp (RBB)
RBB Bancorp operates as the bank holding company for Royal Business Bank that provides various banking products and services to the Chinese-American, Korean-American, and other Asian-American communities. Its deposit products include checking, savings, and money market accounts, as well as certificates of deposit.
RBB Bancorp stock traded up $0.66 during midday trading on Wednesday, hitting $26.46. 25,569 shares of the company were exchanged, compared to its average volume of 113,706. RBB Bancorp has a fifty-two week low of $18.45 and a fifty-two week high of $28.24. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.07 and a current ratio of 1.07. The business has a fifty day simple moving average of $26.23 and a two-hundred day simple moving average of $24.44. The firm has a market capitalization of $447.79 million, a PE ratio of 10.26 and a beta of 1.06.
Read Our Latest Research Report on RBB
Regencell Bioscience (RGC)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Shares of RGC traded down $0.43 during mid-day trading on Wednesday, hitting $5.72. 112,719 shares of the company were exchanged, compared to its average volume of 294,851. The company has a 50 day moving average of $6.86 and a 200-day moving average of $16.92. Regencell Bioscience has a 1-year low of $4.51 and a 1-year high of $69.00.
Read Our Latest Research Report on RGC
China SXT Pharmaceuticals (SXTC)
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.
Shares of NASDAQ:SXTC traded up $0.22 during midday trading on Wednesday, hitting $3.10. The company had a trading volume of 90,632 shares, compared to its average volume of 69,706. China SXT Pharmaceuticals has a twelve month low of $2.71 and a twelve month high of $8,375,880.00. The company has a debt-to-equity ratio of 0.02, a current ratio of 7.94 and a quick ratio of 7.76. The business's 50-day simple moving average is $159.94 and its 200-day simple moving average is $15,364.76.
Read Our Latest Research Report on SXTC
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diageo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diageo wasn't on the list.
While Diageo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
